These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 197258)

  • 1. Clonal transformation of adult human leukocytes by Epstein-Barr virus.
    Sugden B; Mark W
    J Virol; 1977 Sep; 23(3):503-8. PubMed ID: 197258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus DNA is amplified in transformed lymphocytes.
    Sugden B; Phelps M; Domoradzki J
    J Virol; 1979 Sep; 31(3):590-5. PubMed ID: 229241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin.
    Adams A; Bjursell G; Kaschka-Dierich C; Lindahl T
    J Virol; 1977 May; 22(2):373-80. PubMed ID: 194059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Miller G; Lipman M
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.
    Robinson J
    J Virol; 1975 May; 15(5):1065-72. PubMed ID: 167182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.
    Miller G; Lipman M
    J Exp Med; 1973 Dec; 138(6):1398-412. PubMed ID: 4357683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G; Coope D; Niederman J; Pagano J
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication and latency of Epstein-Barr virus.
    Nonoyama M; Tanaka A; Yajima Y
    Bibl Haematol; 1975 Oct; (43):291-6. PubMed ID: 183686
    [No Abstract]   [Full Text] [Related]  

  • 10. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.
    Sternås L; Middleton T; Sugden B
    J Virol; 1990 May; 64(5):2407-10. PubMed ID: 2157896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro.
    Sugden B
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4651-5. PubMed ID: 200925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
    Miller G; Shope T; Lisco H; Stitt D; Lipman M
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):383-7. PubMed ID: 4333982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth in semisolid agar medium of human cord leukocytes freshly transformed by Epstein-Barr virus.
    Mizuno F; Aya T; Osato T
    J Natl Cancer Inst; 1976 Jan; 56(1):171-3. PubMed ID: 176377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Robinson JE; Andiman WA; Henderson E; Miller G
    Proc Natl Acad Sci U S A; 1977 Feb; 74(2):749-53. PubMed ID: 191824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal transformation of human leukocytes by Epstein-Barr virus in soft agar.
    Yamamoto N; Hinuma Y
    Int J Cancer; 1976 Feb; 17(2):191-6. PubMed ID: 175028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
    Bister K; Yamamoto N; zur Hausen H
    Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro.
    Moss DJ; Pope JH
    J Gen Virol; 1972 Nov; 17(2):233-6. PubMed ID: 4344316
    [No Abstract]   [Full Text] [Related]  

  • 18. Three phases in transformation of human lymphocytes by Epstein-Barr virus, as revealed by colony formation in soft agar.
    Harada S; Katsuki T; Hinuma Y
    Microbiol Immunol; 1981; 25(1):23-9. PubMed ID: 6265738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.
    Nyormoi O; Thorley-Lawson DA; Elkington J; Strominger JL
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1745-8. PubMed ID: 179098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid renaturation and restriction endonuclease cleavage analyses show that the DNAs of a transforming and a nontransforming strain of Epstein-Barr virus share approximately 90% of their nucleotide sequences.
    Sugden B; Summers WC; Klein G
    J Virol; 1976 May; 18(2):765-75. PubMed ID: 178907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.